Skip to ContentSkip to Navigation
About us Latest news News News articles

NWO ENW-KLEIN-1 grant for Dr. Vecchi

05 January 2021

Dr. Manuela Vecchi of the Kapteyn Astronomical Institute has been awarded an ENW-KLEIN-1 grant from the Netherlands Organization for Scientific Research (NWO) worth EUR 300,000. The grant is for her project ‘ Cosmic ray antideuterons as a probe for new physics’.

Vecchi focusses on l ight anti-atomic nuclei from space. So far, light anti-atomic nuclei, such as anti-deuterium, have never been detected in cosmic radiation. The detection of these antiparticles is, however, within the reach of the AMS-02 experiment (2011-2024) which involves the collection of data on board the International Space Station. The measurement of flux from anti-atomic nuclei is a particularly promising method for studying antimatter and dark matter accurately.

ENW-KLEIN

The ENW-KLEIN grant offers researchers the opportunity to establish scientific innovations that can form the basis for the research themes of the future. In this round, fifteen applications have been awarded by the board of the NWO. More information about this round is available on the NWO website .

ISS
ISS
Last modified:23 May 2025 08.45 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.